The glutathione transferase Mu null genotype leads to lower 6-MMPR levels in patients treated with azathioprine but not with mercaptopurine

Author(s):
Broekman, M.M.T.J.; Wong, D.R.; Wanten, G.J.A.; Roelofs, H.M.; Marrewijk, C.J. van; Klungel, O.H.; Verbeek, A.L.M.; Hooymans, P.M.; Guchelaar, H.J. (0000-0002-7085-1383); Scheffer, H.; Derijks, L.J.J.; Coenen, M.J.H.; Jong, D.J. de; TOPIC Recruitment Team
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-01-31
Language
English
Is part of
Pharmacogenomics Journal (2018), Vol. 18, no. 1, p. 160-166
hdl
1887/95571
doi
10.1038/tpj.2016.87